Lemaitre Vascular (LMAT) Cash from Operations (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Cash from Operations for 17 consecutive years, with $16.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations fell 21.32% year-over-year to $16.0 million in Q2 2026; TTM through Jun 2026 was $83.0 million, a 41.22% increase from a year earlier, with the FY2025 full-year figure at $81.3 million, up 84.14% from the prior year.
• Cash from Operations was $16.0 million for Q2 2026 at Lemaitre Vascular, up from $15.1 million in the prior quarter.
• Over five years, Cash from Operations peaked at $28.8 million in Q3 2025 and troughed at $2.3 million in Q1 2023.
• A 5-year average of $12.1 million and a median of $11.3 million in 2023 frame the typical range for Cash from Operations.
• The widest YoY moves for Cash from Operations: up 163.58% in 2023, down 51.62% in 2023.
• Over 5 years, Cash from Operations stood at $4.1 million in 2022, then soared by 163.58% to $10.7 million in 2023, then soared by 41.28% to $15.2 million in 2024, then soared by 52.53% to $23.2 million in 2025, then tumbled by 31.06% to $16.0 million in 2026.
• The last three Cash from Operations figures came in at $16.0 million (Q2 2026), $15.1 million (Q1 2026), and $23.2 million (Q4 2025), per Business Quant data.